Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.

Scandinavian journal of gastroenterology - 1 Oct 2005

Teml Alexander, Schwab Matthias, Harrer Marieluise, Miehsler Wolfgang, Schaeffeler Elke, Dejaco Clemens, Mantl Martina, Schneider Barbara, Vogelsang Harald, Reinisch Walter

Abstract excerpt

OBJECTIVE: 6-thioguanine (6-TG) has emerged as a promising therapeutic alternative in patients with Crohn's disease intolerant or resistant to azathioprine (AZA) and/or 6-mercaptopurine (6-MP). The aim of the present study was to evaluate the safety and efficacy of 6-TG in patients with ulcerative colitis (UC) or indeterminate colitis (IC) intolerant or resistant to AZA/6-MP. MATERIAL AND METHODS: Twenty patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azathioprine
Share to Endoscopy, Gastrointestinal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Guanine Nucleotides

Share to Mercaptopurine

Share to Orosomucoid

Share to Patient Compliance

Share to Thioguanine

Share to Thionucleotides

Source

Identifiers

PMID: 16265777
DOI: 10.1080/00365520510023369

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.PMID 16265777Read ↗

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.Semantic proximity Read ↗

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.Semantic proximity Read ↗

Remission maintenance by tioguanine in chronic active Crohn's disease.Semantic proximity Read ↗

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.Semantic proximity Read ↗

Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases.Semantic proximity Read ↗

Review article: thiopurines in inflammatory bowel disease.Semantic proximity Read ↗

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.Semantic proximity Read ↗

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.Semantic proximity Read ↗

Azathioprine and 6‐mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel diseaseSemantic proximity Read ↗

Effective long-term solution to therapeutic remission in Inflammatory Bowel Disease: Role of Azathioprine.Semantic proximity Read ↗

Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.Semantic proximity Read ↗

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.